Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
0.705   -0.01 (1.40%)  0.70 - 0.715  3,284,300
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 923 Million

Market Cap 923 Million
NOSH 1,309 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 24-May-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 24-May-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  30-Sep-2021 [#3]

Latest Quarter: 30-Sep-2021 [#3]
Announcement Date 19-Nov-2021
Next Quarter: 31-Dec-2021
Est. Ann. Date: 17-Mar-2022
Est. Ann. Due Date: 01-Mar-2022
QoQ | YoY   263.65%  |    3,355.96%

Annual (Unaudited) ( EPS: 2.10, P/E: 33.57 )

Revenue | NP to SH 2,725,071  |  27,489
RPS | P/RPS 208.16 Cent  |  0.34
EPS | P/E | EY 2.10 Cent  |  33.57  |  2.98%
DPS | DY | Payout % 2.20 Cent  |  3.12%  |  104.63%
NAPS | P/NAPS 0.26  |  2.74
YoY   118.42%
NP Margin | ROE 0.96%  |  8.15%
F.Y. | Ann. Date 31-Dec-2020  |  17-Mar-2021

T4Q Result ( EPS: 6.14, P/E: 11.49 )

Revenue | NP to SH 4,737,880  |  80,344
RPS | P/RPS 361.91 Cent  |  0.19
EPS | P/E | EY 6.14 Cent  |  11.49  |  8.71%
DPS | DY | Payout % 4.50 Cent  |  6.38%  |  73.30%
NAPS | P/NAPS 0.30  |  2.36
QoQ | YoY   151.46%  |    155.49%
NP Margin | ROE 1.69%  |  20.53%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021

Annualized Result ( EPS: 8.83, P/E: 7.99 )

Revenue | NP to SH 5,471,062  |  115,566
RPS | P/RPS 417.92 Cent  |  0.17
EPS | P/E | EY 8.83 Cent  |  7.99  |  12.52%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   56.85%  |    156.28%
NP Margin | ROE 2.12%  |  29.52%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 4 / 4 100.00% 4 / 8 50.00%
Total Positive Profit Years 3 / 4 75.00% 6 / 8 75.00%
Continuous Quarters Of Positive Profit 3 / 4 75.00% 3 / 8 37.50%
Continuous Quarters Of Profit Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted EPS Growth 1 / 4 25.00% 1 / 8 12.50%
Total Dividend Years 4 / 4 100.00% 7 / 8 88.00%
Continuous Quarters Of Dividend 4 / 4 100.00% 7 / 8 87.50%
Continuous Quarters Of Dividend Growth 3 / 4 75.00% 3 / 8 37.50%
Continuous Quarters Of Adjusted Dps Growth 3 / 4 75.00% 3 / 8 37.50%
Average ROE 5.30% -2.78%
Average Net Profit Margin 1.33% -1.90%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 0 / 5 0.00% 0 / 10 0.00%
Total Positive Profit Years 4 / 5 80.00% 9 / 10 90.00%
Continuous Years Of Positive Profit 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Profit Growth 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Adjusted EPS Growth 1 / 5 20.00% 1 / 10 10.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend Growth 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Adjusted Dps Growth 1 / 5 20.00% 1 / 10 10.00%
Average ROE -1.81% 5.92%
Average Net Profit Margin 0.39% 2.01%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 4,737,880 5,471,062 2,725,071 2,203,575 2,488,707
NP to SH 80,344 115,566 27,489 36,711 4,032
Dividend 58,895 75,056 28,761 45,146 36,666
Adjusted EPS 6.14 8.83 2.10 2.80 0.31
Adjusted DPS 4.50 5.73 2.20 3.45 2.80

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 81.18% 241.34% 96.28% 80.05% 126.16%
NP to Owner 263.65% 3,355.96% 156.28% 148.11% 718.74%
Dividend 33.38% 567.77% 115.35% 77.82% 146.36%
Adj. EPS 263.96% 3,358.93% 156.25% 148.19% 719.68%
Adj. DPS 33.38% 567.77% 115.35% 77.82% 146.36%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 73.86% 90.38% 115.01% 100.77% 119.84% 148.28% -3.38% 9.50% 23.67%
NP to Owner 192.28% 1,892.66% 118.85% 320.41% 2,766.24% 214.80% 118.42% 581.77% -25.12%
Dividend 104.77% 60.63% 30.46% - % - % - % 29.69% -21.56% -36.29%
Adj. EPS 192.41% 1,893.56% 118.95% 320.52% 2,766.96% 214.88% 118.42% 581.77% -25.12%
Adj. DPS 104.82% 60.67% 30.49% - % - % - % 29.69% -21.56% -36.29%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Analyze this stock with MQ Trader system
  5 people like this.
 
Cipta wow! The new Bstead Chairman very powerful! Just One week appointment already win 10 years contract for its subsidiary. Who say flying car can not fly? ^_^ Wish Pharma fly high like Flying Car in year 2022!!!. Wish those bler & ei can win a lot money and need not holiday in KLSEi3 forum at year end but can have proper vocation in Dubai this year! Bravo New Year! Roar!!!!
12/01/2022 9:43 AM
chowwei Wa Lao Er
Sell On News
12/01/2022 11:40 AM
chowwei 哎哟 不错噢 救星到
HLIB 把它救了上来
12/01/2022 12:33 PM
Cyber_moneyman Huat ah.. kasi goreng Pharma kaw²
12/01/2022 6:34 PM
Cyber_moneyman Kasi CNY Ang Pow
12/01/2022 6:34 PM
chowwei 机会是留给 有信心的人
13/01/2022 9:30 AM
VTrade Ppv say sinox3 will take the 4th
14/01/2022 10:59 AM
chowwei 上个星期 星期一
都是 Sell On News
17/01/2022 11:03 AM
chowwei 看来看去 又朝向 0.695
HLIB 不给大力 顶着它
19/01/2022 9:40 AM
chowwei 最近 股市 大红
每天 跟你跌 10点
问你 怕了没
马股 很难 找到吃
19/01/2022 10:03 AM
chowwei 股市 很无情
完全不给 散户
一条生路 过年
19/01/2022 5:36 PM
kfliau 步步惊心!
19/01/2022 5:37 PM
CT Lew Current market needs to trade carefully.
19/01/2022 5:38 PM
kfliau @chowwei 你现在还要谢谢pharma老板吗?
20/01/2022 7:59 AM
Trevor777 Yes, Mr Liau, these people would never listen or see Facts and Figures even when history tells the truth.

Anyway, they are only small kids playing shares for the 1st time, buying only 200 to 300 units for fun. But they sure talk damn big!

They only lose peanuts or gets locked at same price for years.
20/01/2022 8:58 AM
Cipta From recent development, do you still confident on Malaysia SC?

If you are not confident to market regulator on Insider Trading, fake account, misleading info & justly, will you believe Bursa, GLC will hold higher moral ground than SC?

Last week so optimism, shout confident, must trust, good will, reward on good fate; this week moan, shout run, pain, beg to the Croc to give a life line. So cheap a soul who emotion totally controlled by others. Wake up! Think independently!
20/01/2022 10:16 AM
chowwei 耐心成金 时间是 最好良药
20/01/2022 2:56 PM
Trevor777 不见棺材,不流泪
20/01/2022 3:16 PM
Trevor777 Just realised I'm responding to a kid who only bought 200-300 units for fun from his year end bonus! Waste of time.

Let him be locked here at 70c for years.
20/01/2022 3:25 PM
chowwei 慢慢进场 1年 进4次
目标 400,000 Units
目前 216,000 Units
20/01/2022 9:04 PM
chowwei 要写几 Units 人家才会 看懂
如果写 / 几张 / 几粒 / 看不懂
20/01/2022 9:07 PM
chowwei 买 200-300 Units
比如股价是 0.730
200 Units = RM146
300 Units = RM219
只是给水钱都亏死你
21/01/2022 1:36 AM
chowwei 放着它 5年 到 10年
等 再次重来 以前辉煌
21/01/2022 2:08 PM
kfliau 等到花儿也谢了
21/01/2022 7:47 PM
Trevor777 如果相信你拥有216,000 units,母猪可以爬树。
22/01/2022 8:59 AM
chowwei 216,000 Units 大概是 RM170,000
现在 马来西亚 东西那么贵 不算有钱人
22/01/2022 12:34 PM
chowwei 发马 216,000 Units 大概是 RM170,000 左右
现在 马来西亚 东西 变那么贵 不算是有钱人
22/01/2022 12:36 PM
Trevor777 有钱人也不用等年终红利买股!

有人说屁话.
22/01/2022 1:29 PM
Trevor777 USA, deaths due to Covid : more than 850,000 lives

China, deaths due to Covid : more than 4,000

Who is lying?
22/01/2022 1:31 PM
miqie21 China’s zero tolerance policy is very effective.
22/01/2022 7:23 PM
周 海 China is using 'zero tolerance policy' to show its advantage against democratic policies. I thought China has given up the 'zero tolerance policy' a few days ago? By renaming it to something like economic....
22/01/2022 7:33 PM
Legend Pfizer Inc chief executive Albert Bourla said on Saturday that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

Pfizer-BioNtech’s Covid-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission.

With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection.

In an interview with Israel’s N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.

“This will not be a good scenario. What I’m hoping (is) that we will have a vaccine that you will have to do once a year,” Bourla said.

“Once a year – it is easier to convince people to do it. It is easier for people to remember.

“So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variants and that could be a solution,” Bourla said.

Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March.

Citing three studies, the US Centers for Disease Control and Prevention said on Friday that a third dose of an mRNA vaccine is key to fighting Omicron, providing 90% protection against hospitalisation.

A preliminary study published by Israel’s Sheba Medical Center on Monday found that a fourth shot increases antibodies to even higher levels than the third but was likely not enough to fend off Omicron. Nonetheless, a second booster was still advised for risk groups, Sheba said.
23/01/2022 9:26 AM
Cipta Zero Risk Management or Risk Management?

Which is suitable to Malaysia?

Is taking vaccine is a Zero Risk?
If NOT, why take risk to jap since the country is operating in Zero Risk Management.
If YES, And it is effective, and it covers 95% of your population, then the risk should be very low close to normal sickness like flu. Nothing to scare of.

Instead of milking the pharmaceutical companies in huge profit, why not finding the nature HOST ? China has every advantage to find the natural host. With China Speed, sure can find its natural antibody.

**Reminder: A Malaysian Doctor had found the Nipah natural host in only one month 24 years ago.
24/01/2022 8:53 AM
chowwei 如果 现在有人
愿意买 119.1 张
股价就会 冲破 0.740
24/01/2022 10:51 AM
Trevor777 傻子, 你慢慢等....
24/01/2022 1:22 PM
chowwei https://youtu.be/3Y_e8O4ZLgg
RM4200 股息 除于 RM20 等于 210 张股票
https://youtu.be/3Y_e8O4ZLgg
24/01/2022 3:12 PM
chowwei Trevor777
拍 Video 然后 Copy Link 在这里
让我看看 猪怎样爬上树
我吃到那么大 真的没看过 猪爬上树
24/01/2022 3:15 PM
chowwei Trevor777
拍个 Video 然后 Copy Link 到这里
让我开眼界看看 猪到底是怎样爬上树 因为
我吃到那么大 只是听过传说中而已
还没有真正 看过 猪爬上树
24/01/2022 3:19 PM
Trevor777 所以你是, "眼大不见山"
24/01/2022 3:55 PM
chowwei 我不在意 什么 不见猪 不见山 不见海
我只在意 公司要赚大钱 和 公司不会倒闭
24/01/2022 4:52 PM
Cipta https://www.malaysiakini.com/news/608559
27/01/2022 8:51 AM
Cipta Placebo = non protection. Which vaccine you guess most likely if it is true?
27/01/2022 8:53 AM
Cipta https://www.freemalaysiatoday.com/category/nation/2022/01/27/pharmaniaga-chairman-shazalli-redesignated-as-non-independent-director/
27/01/2022 4:08 PM
Cipta UMNO division head is the new Pharma chairman. Go go withdraw your EPF to buy Pharma share. It "will" up to RM2. HOLD it until your cucu give birth your cicit.

This is a Good company. Good products. Good Management. The most important question is: Is it GOOD to you?

Let's see who is the Tiger who is the Goat. Roar~~~~~~
27/01/2022 4:34 PM
kfliau All these political appointees are fleecing the company dry, like felda
27/01/2022 10:59 PM
Karma4444 Umno will help pharmaniaga
28/01/2022 11:38 AM
kfliau Ya, will help it become PN17, lol
28/01/2022 11:47 AM
Trevor777 That Lan-head talked so much, now ran off with tail between legs...hahaha

Die already or not? 70c only.
28/01/2022 12:17 PM
Cipta Since the announcement, from the share price can see Market gives vote of no-confidence.
28/01/2022 8:03 PM
JJPTR RENONG was UMNO COUNTER
SUMATEC UMNO COUNTERS
MRCB UMNO COUNTERS
ALL BECOME NO MO COUNTERS
28/01/2022 8:10 PM